GSA CAPITAL PARTNERS LLP - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 124 filers reported holding CARDLYTICS INC in Q4 2022. The put-call ratio across all filers is 1.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$629
-60.6%
38,135
-84.9%
0.05%
-66.2%
Q2 2023$1,597
+1465.7%
252,736
+741.8%
0.16%
+1500.0%
Q1 2023$102
-87.7%
30,025
-79.0%
0.01%
-90.3%
Q4 2022$826
-99.6%
142,920
+1931.8%
0.10%
+221.9%
Q3 2019$236,0007,0340.03%
Other shareholders
CARDLYTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Antipodean Advisors LLC 638,800$35,121,00025.43%
CAS Investment Partners, LLC 5,416,116$297,778,00019.93%
KPS Global Asset Management UK Ltd 1,218,830$67,011,00016.64%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 546,131$30,026,00012.62%
PB INVESTMENT PARTNERS, L.P. 234,175$12,874,0008.75%
Oakcliff Capital Partners, LP 304,736$16,754,0008.69%
Alua Capital Management LP 1,338,359$73,583,0005.03%
683 Capital Management, LLC 1,569,000$86,264,0004.62%
BERYLSON CAPITAL PARTNERS, LLC 62,700$3,447,0004.04%
JS Capital Management LLC 807,000$44,369,0003.45%
View complete list of CARDLYTICS INC shareholders